Screener Summaries Updates Institutions Sign In More Updates › Leadership & Pay › BIIB Leadership & Pay · Mar 11, 2026
Biogen Chief Legal Officer Susan H. Alexander departs effective end of May 2026 as firm seeks successor BIIB Biogen Inc.
Biogen Inc. announced that Chief Legal Officer Susan H. Alexander will depart the company effective at the end of May 2026. The company has initiated a search for a successor to fill the position. This C-suite transition represents a key leadership change that investors should monitor regarding the company's legal and regulatory oversight.
More from Biogen Inc. Biogen reports Q3 revenue of $2.8B, up 11%, and raises full-year Non-GAAP EPS guidance to $12.20-$13.00 Oct 28, 2026 Biogen reports Q2 revenue of $2.7 billion, raises full-year Non-GAAP EPS guidance to $12–$13 Jul 29, 2026 Biogen expects Q2 charge of $164M, Q3 expense of $290M-$320M impacting EPS by up to $1.95 Jul 1, 2026 Biigen clarifies Apellis acquisition does not constitute significant transaction under Regulation S-X Jun 10, 2026 Biogen completes $5.3B acquisition of Apellis Pharmaceuticals, funded in part by new $2 billion term loan May 14, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
